Bangladesh; Myanmar; Nepal; India; Vietnam; China; Sri Lanka; Thailand
Ingredient ID: NPC99358
Ingredient ID: NPC86373
Ingredient ID: NPC84882
Ingredient ID: NPC75158
Ingredient ID: NPC73411
Ingredient ID: NPC71941
Ingredient ID: NPC70410
Ingredient ID: NPC58970
Ingredient ID: NPC57896
Ingredient ID: NPC55464
Ingredient ID: NPC53011
Ingredient ID: NPC52419
Ingredient ID: NPC478375
Ingredient ID: NPC478374
Ingredient ID: NPC478373
Ingredient ID: NPC478372
Ingredient ID: NPC478371
Ingredient ID: NPC478370
Ingredient ID: NPC478369
Ingredient ID: NPC478368
Ingredient ID: NPC478367
Ingredient ID: NPC478366
Ingredient ID: NPC478365
Ingredient ID: NPC478364
Ingredient ID: NPC478363
Ingredient ID: NPC478362
Ingredient ID: NPC478361
Ingredient ID: NPC478360
Ingredient ID: NPC35655
Ingredient ID: NPC32351
Ingredient ID: NPC321426
Ingredient ID: NPC301972
Ingredient ID: NPC300940
Ingredient ID: NPC292128
Ingredient ID: NPC290052
Ingredient ID: NPC287331
Ingredient ID: NPC284039
Ingredient ID: NPC281772
Ingredient ID: NPC273607
Ingredient ID: NPC256761
Ingredient ID: NPC256070
Ingredient ID: NPC253555
Ingredient ID: NPC242580
Ingredient ID: NPC231738
Ingredient ID: NPC23049
Ingredient ID: NPC229
Ingredient ID: NPC221754
Ingredient ID: NPC215711
Ingredient ID: NPC212695
Ingredient ID: NPC201817
Ingredient ID: NPC192996
Ingredient ID: NPC190664
Ingredient ID: NPC183670
Ingredient ID: NPC180170
Ingredient ID: NPC175674
Ingredient ID: NPC173996
Ingredient ID: NPC166362
Ingredient ID: NPC163984
Ingredient ID: NPC161423
Ingredient ID: NPC160900
Ingredient ID: NPC160416
Ingredient ID: NPC154893
Ingredient ID: NPC142871
Ingredient ID: NPC142759
Ingredient ID: NPC141777
Ingredient ID: NPC139397
Ingredient ID: NPC138208
Ingredient ID: NPC138142
Ingredient ID: NPC133976
Ingredient ID: NPC130193
Ingredient ID: NPC115568
Ingredient ID: NPC111492
Ingredient ID: NPC109219
Ingredient ID: NPC109083
Target Type | Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|---|
Cytochrome P450 | Cytochrome P450 family 19 | CYP19A1 | Cytochrome P450 19A1 | P11511 | CHEMBL1978 |
Therapeutic Target | Isomerase | PTGES | Prostaglandin E synthase | O14684 | CHEMBL5658 |
Therapeutic Target | Lyase | GLO1 | Glyoxalase I | Q04760 | CHEMBL2424 |
Therapeutic Target | Lyase | CA2 | Carbonic anhydrase II | P00918 | CHEMBL205 |
Therapeutic Target | Nuclear hormone receptor subfamily 3 | AR | Androgen Receptor | P10275 | CHEMBL1871 |
Therapeutic Target | Oxidoreductase | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P00352 | CHEMBL3577 |
Therapeutic Target | Oxidoreductase | ALOX5 | Arachidonate 5-lipoxygenase | P09917 | CHEMBL215 |
Therapeutic Target | Oxidoreductase | HSD17B3 | Estradiol 17-beta-dehydrogenase 3 | P37058 | CHEMBL4234 |
Therapeutic Target | Peptide receptor (family A GPCR) | NPSR1 | Neuropeptide S receptor | Q6W5P4 | CHEMBL5162 |
Therapeutic Target | Peptide receptor (family A GPCR) | TSHR | Thyroid stimulating hormone receptor | P16473 | CHEMBL1963 |
Therapeutic Target | Protein Kinase | MAP3K7 | Mitogen-activated protein kinase kinase kinase 7 | O43318 | CHEMBL5776 |
Therapeutic Target | Protein Kinase | MAP2K1 | Dual specificity mitogen-activated protein kinase kinase 1 | Q02750 | CHEMBL3587 |
Therapeutic Target | Protein Kinase | MAPK1 | MAP kinase ERK2 | P28482 | CHEMBL4040 |
Therapeutic Target | Protein Kinase | MAP2K7 | Dual specificity mitogen-activated protein kinase kinase 7 | O14733 | CHEMBL3530 |
Therapeutic Target | Secreted protein | SERPINA6 | Corticosteroid binding globulin | P08185 | CHEMBL2421 |
Therapeutic Target | Secreted protein | SHBG | Testis-specific androgen-binding protein | P04278 | CHEMBL3305 |
Therapeutic Target | Structural protein | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
Therapeutic Target | Surface antigen | F3 | Coagulation factor III | P13726 | CHEMBL4081 |
Therapeutic Target | Transcription factor | RELA | Nuclear factor NF-kappa-B p65 subunit | Q04206 | CHEMBL5533 |
Therapeutic Target | Transferase | GSTP1 | Glutathione S-transferase Pi | P09211 | CHEMBL3902 |
Therapeutic Target | Unclassified protein | PLAA | Phospholipase A-2-activating protein | Q9Y263 | CHEMBL6114 |
Drug Transporter | Voltage-gated calcium channel | CACNA1C | Voltage-gated L-type calcium channel alpha-1C subunit | Q13936 | CHEMBL1940 |
Clinical trials associated with plant from natural product (NP) & plant level:
Clinical trials type | Number of clinical trials | |
---|---|---|
NP level | 211 | |
NCT ID | Title | Condition | Form in clinical use | Associated by plant or compound |
---|---|---|---|---|
NCT00075855 | Low-Dose Testosterone in Improving Libido in Postmenopausal Female Cancer Survivors | sexual dysfunction | Testosterone (NPC161423) | NP level |
NCT04558567 | Testopel ® vs. Generic Testosterone Pellets. | hypogonadism | Testosterone (NPC161423) | NP level |
NCT00006158 | AIDS Wasting in Women: Anabolic Effects of Testosterone | AIDS | Testosterone (NPC161423) | NP level |
NCT00372008 | Pharmacokinetics of Testosterone Lotion in the Treatment of Hypogonadal Males | hypogonadism | Testosterone (NPC161423) | NP level |
NCT02100423 | Curcumin and Cholecalciferol in Treating Patients With Previously Untreated Stage 0-II Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma | chronic lymphocytic leukemia | Curcumin (NPC109083) | NP level |
NCT01246973 | Oral Curcumin for Radiation Dermatitis | radiodermatitis | Curcumin (NPC109083) | NP level |
NCT01697345 | Breast Cancer, Aromatase Inhibitor Therapy, and Sexual Functioning: The Effects of Vaginal Testosterone Therapy | Dyspareunia | Testosterone (NPC161423) | NP level |
NCT00962637 | Study to Evaluate the Safety and Efficacy of Androxal™ Treatment in Men With Secondary Hypogonadism | hypogonadotropic hypogonadism | Testosterone (NPC161423) | NP level |
NCT02439385 | Avastin/FOLFIRI in Combination With Curcumin in Colorectal Cancer Patients With Unresectable Metastasis | colorectal carcinoma | Curcumin (NPC109083) | NP level |
NCT00998933 | Study of Serum Testosterone Levels in Non-dosed Females After Secondary Exposure | hypogonadism | Testosterone (NPC161423) | NP level |
NCT02147964 | ITT-5 Mechanisms of Spermatogenesis in Man | hypogonadism | Testosterone (NPC161423) | NP level |
NCT01419236 | A Study of Ejaculatory Dysfunction in Men With Low Testosterone Levels | hypogonadism | Testosterone (NPC161423) | NP level |
NCT01042938 | Curcumin for the Prevention of Radiation-induced Dermatitis in Breast Cancer Patients | breast cancer | Curcumin (NPC109083) | NP level |
NCT04439799 | A Comparison of Side Effects in Hypogonadal Men Treated With Natesto Versus Testosterone Injections | hypogonadism | Testosterone (NPC161423) | NP level |
NCT01608139 | Study of Curcumin, Vorinostat, and Sorafenib | cancer | Curcumin (NPC109083) | NP level |
NCT02712944 | Testosterone Replacement in Renal Failure | hypogonadism | Testosterone (NPC161423) | NP level |
NCT00706719 | To Evaluate Sperm Parameters in Men With Secondary Hypogonadism Previously Treated With Topical Testosterone | hypogonadotropic hypogonadism | Testosterone (NPC161423) | NP level |
NCT02418065 | Multimodal Therapeutic Approach in Undernourished Maintenance Hemodialysis Patients (AMERICANO) | chronic kidney disease | Testosterone (NPC161423) | NP level |
NCT01048983 | Reducing Symptom Burden - Non Small Cell Lung Cancer (NSCLC) | non-small cell lung carcinoma | Curcumin (NPC109083) | NP level |
NCT02937740 | Open-Label Study, Evaluating Patient Satisfaction and Symptom Improvement When Treating Male Hypogonadism With Natesto™ | hypogonadism | Testosterone (NPC161423) | NP level |
NCT01740323 | Phase II Study of Curcumin vs Placebo for Chemotherapy-Treated Breast Cancer Patients Undergoing Radiotherapy | breast cancer | Curcumin (NPC109083) | NP level |
NCT04492553 | Gonadal Dysfunction in Male Long-term Survivors of Malignant Lymphoma | hypogonadism | Testosterone (NPC161423) | NP level |
NCT00226174 | A Randomized, Placebo-Controlled, Double-Blind Clinical Trial of Curcuminoids in Oral Lichen Planus | oral lichen planus | Curcumin (NPC109083) | NP level |
NCT01127659 | Testosterone Replacement in Men With Diabetes and Obesity | hypogonadism | Testosterone (NPC161423) | NP level |
NCT01859858 | Effect of Curcumin on Dose Limiting Toxicity and Pharmacokinetics of Irinotecan in Patients With Solid Tumors | colorectal cancer | Curcumin (NPC109083) | NP level |
NCT00161486 | The Effects of Testosterone on Prostate Tissue (ACYP-1) | hypogonadism | Testosterone (NPC161423) | NP level |
NCT05147376 | Effectiveness of a Curcumin Mouthwash in Preventing Traumatic Ulcers in Patients With Fixed Orthodontic Appliances | Oral ulcer | Curcumin (NPC109083) | NP level |
NCT02419105 | Effects of Transdermal Testosterone and/or Monthly Vitamin D on Fall Risk in Pre--frail Hypogonadal Seniors | hypogonadism | Testosterone (NPC161423) | NP level |
NCT01320436 | Curcumin + Aminosalicylic Acid (5ASA) Versus 5ASA Alone in the Treatment of Mild to Moderate Ulcerative Colitis | ulcerative colitis | Curcumin (NPC109083) | NP level |
NCT02782949 | Curcumin in Preventing Gastric Cancer in Patients With Chronic Atrophic Gastritis or Gastric Intestinal Metaplasia | atrophic gastritis | Curcumin (NPC109083) | NP level |
NCT00586898 | Rapid Hormonal Cycling as Treatment for Patients With Prostate Cancer: The Men's Cycle | prostate carcinoma | Testosterone (NPC161423) | NP level |
NCT03790605 | A Clinical Trial to Study the Effect of a Drug, Curcumin in Patients With Periodontitis | periodontitis | Curcumin (NPC109083) | NP level |
NCT01816295 | A Study in Men With Low Testosterone to Measure the Effects of Testosterone Solution on Testosterone Levels, Sex Drive and Energy | hypogonadism | Testosterone (NPC161423) | NP level |
NCT04523480 | Vitality | hypogonadism | Testosterone (NPC161423) | NP level |
NCT00400335 | Study On Bioavailability And Pharmacokinetics Of Various Doses Of Testosterone Administered With And Without Dutasteride | hypogonadism | Testosterone (NPC161423) | NP level |
NCT00244023 | Co-Administering Testosterone With PDE5 Inhibitors in ED Patients Non Responders to PDE5 Inhibitors Alone | erectile dysfunction;hypogonadism | Testosterone (NPC161423) | NP level |
NCT04713631 | Safety and Efficacy of Artesunate & Curcumin in Crohn's Disease | Crohn's disease | Curcumin (NPC109083) | NP level |
NCT00702650 | A Titration Trial to Determine the Effectiveness of Testosterone MD-Lotion (Cutaneous Solution) Formulations | hypogonadism | Testosterone (NPC161423) | NP level |
NCT00438321 | Effect of Increasing Testosterone on Insulin Sensitivity in Men With the Metabolic Syndrome | metabolic syndrome | Testosterone (NPC161423) | NP level |
NCT05430087 | Vitamin D and Curcumin Piperine Attenuates Disease Activity and Cytokine Levels in Systemic Lupus Erythematosus Patients | systemic lupus erythematosus | Curcumin (NPC109083) | NP level |
NCT02445716 | Transdermal Testosterone Nanoemulsion in Women Libido | menopause | Testosterone (NPC161423) | NP level |
NCT00852332 | Docetaxel With or Without a Phytochemical in Treating Patients With Breast Cancer | breast cancer | Curcumin (NPC109083) | NP level |
NCT02095717 | Multicenter Study Comparing Taxotere Plus Curcumin Versus Taxotere Plus Placebo Combination in First-line Treatment of Prostate Cancer Metastatic Castration Resistant (CURTAXEL) | prostate cancer | Curcumin (NPC109083) | NP level |
NCT00889161 | Curcumin in Pediatric Inflammatory Bowel Disease | Crohn's disease;ulcerative colitis | Curcumin (NPC109083) | NP level |
NCT00431197 | Steady-State Feedback Actions of Testosterone on Luteinizing Hormone Secretion in Young and Older Men | hypogonadism | Testosterone (NPC161423) | NP level |
NCT04870060 | Ability of Curcumin to Decrease Cytokines Involved in Mucositis in the Autologous Transplant | oral mucositis | Curcumin (NPC109083) | NP level |
NCT00131495 | Study of Transdermal Testosterone Patches in Menopausal Women With Low Libido | sexual dysfunction | Testosterone (NPC161423) | NP level |
NCT00969085 | Trial of Curcumin in Cutaneous T-cell Lymphoma Patients | Cutaneous T-cell lymphoma | Curcumin (NPC109083) | NP level |
NCT03511261 | Efficacy of Curcumin in Oral Submucous Fibrosis | oral submucous fibrosis | Curcumin (NPC109083) | NP level |
NCT03345797 | Evaluation of Testosterone Nasal Gel in Hypogonadal Boys | hypogonadism | Testosterone (NPC161423) | NP level |
NCT01887418 | Pharmacokinetic Study of Testosterone Enanthate | hypogonadism | Testosterone (NPC161423) | NP level |
NCT01811381 | Curcumin and Yoga Therapy for Those at Risk for Alzheimer's Disease | Cognitive impairment | Curcumin (NPC109083) | NP level |
NCT00006044 | Testosterone in Treating Patients With Progressive Prostate Cancer That No Longer Responds to Hormone Therapy | prostate cancer | Testosterone (NPC161423) | NP level |
NCT00349791 | Study to Assess the Efficacy/Safety of Transdermal Testosterone Patches in Naturally Menopausal Women With Low Libido | sexual dysfunction | Testosterone (NPC161423) | NP level |
NCT02978339 | A Study Evaluating the Safety and Efficacy of Curcumin in Patients With Primary Sclerosing Cholangitis (PSC) | sclerosing cholangitis | Curcumin (NPC109083) | NP level |
NCT01699178 | Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal Men | hypogonadism | Testosterone (NPC161423) | NP level |
NCT00433199 | Testosterone Treatment for Hypogonadal Men | hypogonadism | Testosterone (NPC161423) | NP level |
NCT01160328 | Influence of Male Hormones on Regional Fat Metabolism | obesity | Testosterone (NPC161423) | NP level |
NCT04837664 | Curcumin | nicotine dependence | Curcumin (NPC109083) | NP level |
NCT01386567 | A One Year Open Label Study for the Treatment of Hypogonadism (Low Testosterone) in Men Who Have Completed ZA-203 | hypogonadism | Testosterone (NPC161423) | NP level |
NCT05062486 | A Study to Evaluate the Safety and Efficacy of RQC for AMD | age-related macular degeneration | Curcumin (NPC109083) | NP level |
NCT02944578 | Topical Curcumin for Precancer Cervical Lesions | neoplasm | Curcumin (NPC109083) | NP level |
NCT02300727 | Study to See How Safe Curcumin is and How Well it Works When Used to Treat Mucositis in Patients Getting Chemotherapy | mucositis | Curcumin (NPC109083) | NP level |
NCT01993212 | A Randomized, Double Blind, Placebo-Controlled, Multi-Center Phase III Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Testosterone and Sperm Concentration Following Treatment With 12.5 mg or 25 mg Androxal or AndroGel 1.62% | hypogonadotropic hypogonadism | Testosterone (NPC161423) | NP level |
NCT04294836 | Curcumin in Advanced Cervical Cancer | cervical cancer | Curcumin (NPC109083) | NP level |
NCT02873559 | Effect of PROGRESSive Training and Teststerone in Older Frail Men | muscular disease | Testosterone (NPC161423) | NP level |
NCT00338312 | Study of Transdermal Testosterone Patches in Naturally Menopausal Women With Low Libido | sexual dysfunction | Testosterone (NPC161423) | NP level |
NCT00248053 | Use of Curcumin in the Lower Gastrointestinal Tract in Familial Adenomatous Polyposis Patients | Familial adenomatous polyposis | Curcumin (NPC109083) | NP level |
NCT00202163 | ANDRO 2002: Dehydroepiandrosterone (DHEA) or Testosterone Versus Placebo in Men With Sexual Dysfunction | erectile dysfunction | Testosterone (NPC161423) | NP level |
NCT00613002 | Safety and Efficacy of LibiGel® for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women | sexual dysfunction | Testosterone (NPC161423) | NP level |
NCT03118479 | Effect of Varying Testosterone Levels on Insulin Sensitivity in Men With Idiopathic Hypogonadotropic Hypogonadism (IHH) | Kallmann syndrome | Testosterone (NPC161423) | NP level |
NCT00304213 | Does Testosterone Improve Function in Hypogonadal Older Men | hypogonadism | Testosterone (NPC161423) | NP level |
NCT00295035 | Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Metastatic Colon Cancer | colonic neoplasm | Curcumin (NPC109083) | NP level |
NCT00957034 | Assessing the Safety/Efficacy of Transdermal Testosterone in Female Patients With Symptomatic Heart Failure | heart failure | Testosterone (NPC161423) | NP level |
NCT02317263 | A Trial to Investigate the Effectiveness of Testosterone Treatment in Men With Multiple Sclerosis | multiple sclerosis | Testosterone (NPC161423) | NP level |
NCT04266275 | Topical Curcumin for HPV Related Cervical Disease | cervical adenocarcinoma | Curcumin (NPC109083) | NP level |
NCT02529982 | Curcumin Supplementation and Patients With Type 2 Diabetes | type 1 diabetes mellitus | Curcumin (NPC109083) | NP level |
NCT05045443 | Safety and Efficacy of Curcumin in Children With Acute Lymphoblastic Leukemia | acute lymphoblastic leukemia | Curcumin (NPC109083) | NP level |
NCT02847806 | Effects of Replacement Therapy With Sexual Steroid Hormones on the Insulin Sensitivity of Hypogonadal Man | hypogonadism | Testosterone (NPC161423) | NP level |
NCT01133548 | Pharmacokinetic and Comparative Bioavailability Study of Testosterone Absorption After Administration of Testosterone Gel 1.62% to the Upper Arms/Shoulders Using an Application Site Rotation or a Combination of Application Sites in Hypogonadal Males | hypogonadism | Testosterone (NPC161423) | NP level |
NCT00183040 | HORMA: Hormonal Regulators of Muscle and Metabolism in Aging | sarcopenia | Testosterone (NPC161423) | NP level |
NCT02081300 | Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism | hypogonadism | Testosterone (NPC161423) | NP level |
NCT02990533 | Muscle Anabolic Interventions to Accelerate Recovery From Hospitalization in Geriatric Patients | aging | Testosterone (NPC161423) | NP level |
NCT01269203 | Efficacy of NF-kB Inhibition for Reducing Symptoms During Maintenance Therapy in Multiple Myeloma Patients | multiple myeloma | Curcumin (NPC109083) | NP level |
NCT01370369 | Efficacy, Pharmacokinetics and Safety of Testosterone | hypogonadism | Testosterone (NPC161423) | NP level |
NCT04353310 | Evaluating Effects of Curcumin in Moderate to Severe Asthmatics | asthma | Curcumin (NPC109083) | NP level |
NCT00528151 | A Randomized, Double-blind, Placebo-controlled Trial of Curcumin in Leber's Hereditary Optic Neuropathy (LHON) | Leber hereditary optic neuropathy | Curcumin (NPC109083) | NP level |
NCT03980509 | A "Window Trial" on Curcumin for Invasive Breast Cancer Primary Tumors | breast cancer | Curcumin (NPC109083) | NP level |
NCT00405353 | Testosterone Treatment for Multiple Sclerosis | multiple sclerosis | Testosterone (NPC161423) | NP level |
NCT01035580 | Trial on Safety and Pharmacokinetics of Intravaginal Curcumin | dysplasia of cervix | Curcumin (NPC109083) | NP level |
NCT01294072 | Study Investigating the Ability of Plant Exosomes to Deliver Curcumin to Normal and Colon Cancer Tissue | malignant colon neoplasm | Curcumin (NPC109083) | NP level |
NCT00957528 | Cycled Testosterone Replacement Study | hypogonadism | Testosterone (NPC161423) | NP level |
NCT00857454 | A Trial to Evaluate the Ongoing Skin Safety of Testosterone MD-Lotion Formulations | hypogonadism | Testosterone (NPC161423) | NP level |
NCT00657501 | Safety and Efficacy of LibiGel® for Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women | sexual dysfunction | Testosterone (NPC161423) | NP level |
NCT00398580 | 28-Day Study of Testosterone Co-administered With Dutasteride in Hypogonadal Men | hypogonadism | Testosterone (NPC161423) | NP level |
NCT00479609 | Testosterone Therapy in Men With Low Testosterone Levels and Metabolic Syndrome or Early Stages of Type 2 Diabetes | metabolic syndrome | Testosterone (NPC161423) | NP level |
NCT00757185 | Compromised Microcirculation in Women With Polycystic Ovary Syndrome | polycystic ovary syndrome | Testosterone (NPC161423) | NP level |
NCT00118989 | Curcumin for the Chemoprevention of Colorectal Cancer | Familial adenomatous polyposis | Curcumin (NPC109083) | NP level |
NCT03281187 | Efficacy and Safety of Testosterone Nasal Gel for Treating Hypogonadism in Men. | hypogonadism | Testosterone (NPC161423) | NP level |
NCT04590196 | Effect of Oral Curcumin Supplementation in Dry Age-related Macular Degeneration (AMD) Patients | age-related macular degeneration | Curcumin (NPC109083) | NP level |
NCT00587431 | Docetaxel With Rapid Hormonal Cycling as a Treatment for Patients With Prostate Cancer | prostate cancer | Testosterone (NPC161423) | NP level |
NCT02277223 | Curcumin in Pediatric Ulcerative Colitis | ulcerative colitis | Curcumin (NPC109083) | NP level |
NCT04265053 | Human Cerebral Blood Flow Regulation | cerebral arterial disease | Testosterone (NPC161423) | NP level |
NCT04274894 | A Study of the Effect of Topical Testosterone Replacement Therapy on Blood Pressure in Adult Male Participants With Hypogonadism | hypogonadism | Testosterone (NPC161423) | NP level |
NCT02679274 | Cycled Testosterone Therapy to Improve Physical Function in Frail Nursing Home Residents | aging | Testosterone (NPC161423) | NP level |
NCT01096329 | A Pharmacokinetic (PK) Study to Compare the Absorption of Two Formulations of Transdermal Testosterone Spray and Intrinsa® | sexual dysfunction | Testosterone (NPC161423) | NP level |
NCT00413244 | The Cardiac Benefit of Testosterone Replacement in Men With Low Testosterone Levels With Coronary Artery Disease After Successful Intervention of the Blockage or Narrowed Heart Artery | coronary artery disease | Testosterone (NPC161423) | NP level |
NCT00745134 | Radiation Therapy and Capecitabine With or Without Curcumin Before Surgery in Treating Patients With Rectal Cancer | rectal carcinoma | Curcumin (NPC109083) | NP level |
NCT00382057 | Testosterone Effects on Men With the Metabolic Syndrome | metabolic syndrome | Testosterone (NPC161423) | NP level |
NCT03734653 | Testosterone Therapy in Castration Resistant Prostate Cancer | prostate cancer | Testosterone (NPC161423) | NP level |
NCT00161421 | Oral Androgens in Man-3 (ORAL T-3) Pharmacokinetics of Oral Testosterone | hypogonadism | Testosterone (NPC161423) | NP level |
NCT01703741 | A Multicenter Extension Trial to Evaluate the Safety of Testosterone Gel | hypogonadism | Testosterone (NPC161423) | NP level |
NCT00698035 | Vaginal Testosterone Cream vs ESTRING for Vaginal Dryness or Decreased Libido in Early Stage Breast Cancer Patients | sexual dysfunction | Testosterone (NPC161423) | NP level |
NCT01469988 | The VO2 Increase With Testosterone Addition - Heart Failure (VITA-HF) Trial | heart failure | Testosterone (NPC161423) | NP level |
NCT03238092 | Comparison Between Testosterone and Estradiol Over the Homogenization of Follicular Cohort | infertility | Testosterone (NPC161423) | NP level |
NCT02138955 | A Phase IB Dose Escalation Study of Lipocurc in Patients With Cancer | cancer | Curcumin (NPC109083) | NP level |
NCT01323140 | Pharmacokinetics, Metabolism, Efficacy, and Safety Study of Two Testosterone Matrix Transdermal Systems | hypogonadism | Testosterone (NPC161423) | NP level |
NCT03198728 | Efficacy and Safety of Oral Testosterone Undecanoate in Hypogonadal Men | hypogonadism | Testosterone (NPC161423) | NP level |
NCT00345969 | Exercise and Testosterone Therapy in Elderly Men With Physical Frailty | hip fracture;hypogonadism | Testosterone (NPC161423) | NP level |
NCT02111473 | The Effect of Testosteron Replacement Treatment on the Fibroblast Growth Factor-23, Asymmetric Dimethylarginine and Vitamin D Levels in the Congenital Hypogonadotropic Hypogonadism | hypogonadism | Testosterone (NPC161423) | NP level |
NCT01201694 | Phase I Study of Surface-Controlled Water Soluble Curcumin (THERACURMIN CR-011L) | cancer | Curcumin (NPC109083) | NP level |
NCT01252745 | Efficacy of an Intranasal Testosterone Product | hypogonadism | Testosterone (NPC161423) | NP level |
NCT03345576 | Testosterone and Long Pulse Stimulation After SCI | Spinal cord injury | Testosterone (NPC161423) | NP level |
NCT05011383 | High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers | metastatic prostate cancer | Testosterone (NPC161423) | NP level |
NCT00612742 | Safety and Efficacy of LibiGel® for Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women | sexual dysfunction | Testosterone (NPC161423) | NP level |
NCT01578473 | Testosterone Pellets Plus Vitamin D and E Versus Vitamin D and E Alone for the Treatment of Peyronie's Disease | Abnormality of connective tissue | Testosterone (NPC161423) | NP level |
NCT03953261 | Effect of Curcumin on Systemic Lupus Erythematosus | systemic lupus erythematosus | Curcumin (NPC109083) | NP level |
NCT03019848 | Effect of Oral Supplementation With Curcumin in Patients With Proteinuric Diabetic Kidney Disease | Proteinuria | Curcumin (NPC109083) | NP level |
NCT02645656 | Topical Application of Curcumin Orabase in Oral Submucous Fibrosis (OSMF) | oral submucous fibrosis | Curcumin (NPC109083) | NP level |
NCT00577980 | Testosterone in Castration-Resistant Prostate Cancer | prostate cancer | Testosterone (NPC161423) | NP level |
NCT03769766 | Trial of Curcumin to Prevent Progression of Low-risk Prostate Cancer Under Active Surveillance | prostate cancer | Curcumin (NPC109083) | NP level |
NCT01514370 | Dietary Supplement of Curcumin in Subjects With Active Relapsing Multiple Sclerosis Treated With Subcutaneous Interferon Beta 1a | multiple sclerosis | Curcumin (NPC109083) | NP level |
NCT04403568 | Testing the Synergism of Phytonutrients, Curcumin and Ursolic Acid, to Target Molecular Pathways in the Prostate | prostate cancer | Curcumin (NPC109083) | NP level |
NCT00309855 | Testosterone-Driven Growth-Hormone (GH) Secretion in Aging Men | aging | Testosterone (NPC161423) | NP level |
NCT02110368 | Bioequivalence Study of Test and Reference Testosterone Topical Gel, 1.62% Metered Pump in Testosterone Deficient Adult Male Subjects Under Fasting Conditions | hypogonadotropic hypogonadism | Testosterone (NPC161423) | NP level |
NCT00089843 | Bone Loss in Women With Anorexia Nervosa | anorexia nervosa | Testosterone (NPC161423) | NP level |
NCT01786473 | Testogel® (Testosterone Gel 50mg/5g) in the Treatment of Male Hypogonadism | hypogonadism | Testosterone (NPC161423) | NP level |
NCT01270841 | Normalization of Morning Testosterone Levels in Men With Secondary Hypogonadism | hypogonadotropic hypogonadism | Testosterone (NPC161423) | NP level |
NCT01119534 | Comparative Efficacy of the Suppository Versus Guaiacol Suppository Versus Guaifenesin Syrup in Pediatric Patients With Cough Due the Infectious Origin | Cough | Eucalyptol (NPC287331) | NP level |
NCT02101203 | Lybridos in Pre-and Postmenopausal Women With Hypoactive Sexual Desire Disorder | sexual dysfunction | Testosterone (NPC161423) | NP level |
NCT02369549 | Micro-Particle Curcumin for the Treatment of Chronic Kidney Disease | chronic kidney disease | Curcumin (NPC109083) | NP level |
NCT01383161 | 18-Month Study of Memory Effects of Curcumin | Cognitive impairment | Curcumin (NPC109083) | NP level |
NCT02203656 | Feasibility Study of Post-hospitalization Interventions to Improve Physical Function in Older Adults | aging | Testosterone (NPC161423) | NP level |
NCT00099710 | Curcumin in Patients With Mild to Moderate Alzheimer's Disease | Alzheimer disease | Curcumin (NPC109083) | NP level |
NCT03000127 | Testosterone for Fatigue in Men With MS | multiple sclerosis | Testosterone (NPC161423) | NP level |
NCT01616732 | Testosterone and Weight Loss | obesity | Testosterone (NPC161423) | NP level |
NCT02255370 | Curcumin Associated With Thiopurin in the Prevention of Post-op Recurrence in Crohn Disease | Crohn's disease | Curcumin (NPC109083) | NP level |
NCT02554344 | Effect of Curcumin in Treatment of Squamous Cervical Intraepithelial Neoplasias (CINs) | cervical intraepithelial neoplasia | Curcumin (NPC109083) | NP level |
NCT01831193 | Effect of Oral Supplementation With Curcumin (Turmeric) in Patients With Proteinuric Chronic Kidney Disease | Proteinuria | Curcumin (NPC109083) | NP level |
NCT01652040 | Resistance Training and Testosterone After Spinal Cord Injury | Spinal cord injury | Testosterone (NPC161423) | NP level |
NCT00192842 | Gemcitabine With Curcumin for Pancreatic Cancer | pancreatic carcinoma | Curcumin (NPC109083) | NP level |
NCT00365209 | Phase II A Trial of Curcumin Among Patients With Prevalent Subclinical Neoplastic Lesions (Aberrant Crypt Foci) | nicotine dependence | Curcumin (NPC109083) | NP level |
NCT01403116 | Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men | hypogonadism | Testosterone (NPC161423) | NP level |
NCT00857961 | A Study of the Pharmacokinetics of Testosterone Metered Dose (MD)-Lotion Formulations | hypogonadism | Testosterone (NPC161423) | NP level |
NCT02848417 | Glutathione vs. Curcumin Clinical Trial | persian gulf syndrome | Curcumin (NPC109083) | NP level |
NCT00486460 | Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Advance or Inoperable Pancreatic Cancer | pancreatic carcinoma | Curcumin (NPC109083) | NP level |
NCT03072992 | "Curcumin" in Combination With Chemotherapy in Advanced Breast Cancer | breast cancer | Curcumin (NPC109083) | NP level |
NCT00641147 | Curcumin in Treating Patients With Familial Adenomatous Polyposis | Familial adenomatous polyposis | Curcumin (NPC109083) | NP level |
NCT00254553 | A Study to Test a Measure of Symptoms of Older Men With Low Testosterone On and Off Testosterone Replacement Treatment (P05815) | hypogonadism | Testosterone (NPC161423) | NP level |
NCT04355416 | Clinical and Anti-inflammatory Effect of Curcumin Oral Gel as Adjuncts in Treatment of Periodontal Pocket | periodontitis | Curcumin (NPC109083) | NP level |
NCT00204269 | Three-Year Trial on a New Testosterone Gel | hypogonadism | Testosterone (NPC161423) | NP level |
NCT00515112 | Testosterone Replacement in Men With Non-Metastatic Castrate Resistant Prostate Cancer | prostate cancer | Testosterone (NPC161423) | NP level |
NCT04976595 | Vogelxo(R) ABPM Study in Hypogandal Men | hypogonadism | Testosterone (NPC161423) | NP level |
NCT00384046 | Testosterone Therapy in Naturally Menopausal Women With Low Sexual Desire Receiving Transdermal Estrogen | sexual dysfunction | Testosterone (NPC161423) | NP level |
NCT01665599 | A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel | hypogonadism | Testosterone (NPC161423) | NP level |
NCT04831099 | Testosterone Treatment in a Patient With 17β-hydroxysteroid Dehydrogenase Type 3 Deficiency: an N-of-1 Study | Genetic disorder of sex development | Testosterone (NPC161423) | NP level |
NCT00705796 | Influence of Administration Route of Testosterone on Male Fertility | hypogonadism | Testosterone (NPC161423) | NP level |
NCT01432665 | Lybrido for Female Sexual Dysfunction | sexual dysfunction | Testosterone (NPC161423) | NP level |
NCT02149264 | A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel in Adult Hypogonadal Males | hypogonadism | Testosterone (NPC161423) | NP level |
NCT00080756 | Deslorelin Combined With Low-Dose Add-Back Estradiol and Testosterone in Preventing Breast Cancer in Premenopausal Women Who Are at High Risk for This Disease | Hereditary breast and ovarian cancer syndrome | Testosterone (NPC161423) | NP level |
NCT01993225 | A Randomized, Double Blind, Placebo-Controlled, Multi-Center Phase III Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Testosterone and Sperm Concentration Following Treatment With 12.5 mg or 25 mg Androxal or AndroGel 1.62% | hypogonadotropic hypogonadism | Testosterone (NPC161423) | NP level |
NCT03378713 | Clinical Trial to Assess the Effect of Testosterone in Patients With Poor Ovarian Response (TESTOPRIM) | infertility | Testosterone (NPC161423) | NP level |
NCT01333917 | Curcumin Biomarkers | colorectal carcinoma | Curcumin (NPC109083) | NP level |
NCT01797718 | Constitutional Delay of Growth and Puberty: Towards Evidence-based Treatment | Growth delay | Testosterone (NPC161423) | NP level |
NCT01446042 | Safety and Efficacy of Intranasal TBS-1 Treatment of Male Hypogonadism | hypogonadism | Testosterone (NPC161423) | NP level |
NCT02529969 | Effects of Curcumin Supplementation on Lipid Profile and Inflammatory Markers of Patients With Type 2 Diabetes | type 1 diabetes mellitus | Curcumin (NPC109083) | NP level |
NCT02722278 | A Study of Oral Testosterone Undecanoate (TU) in Hypogonadal Men | hypogonadism | Testosterone (NPC161423) | NP level |
NCT00973869 | Curcumin in Preventing Colorectal Cancer in Patients Undergoing Colorectal Endoscopy or Colorectal Surgery | colorectal carcinoma | Curcumin (NPC109083) | NP level |
NCT00857168 | To Determine the Effects of Deodorant, Antiperspirant and Washing on the Pharmacokinetics of 2% Testosterone MD Lotion | hypogonadism | Testosterone (NPC161423) | NP level |
NCT01364623 | PK Study of Testosterone Nasal Gel (TBS-2) in Healthy Premenopausal Women | sexual dysfunction | Testosterone (NPC161423) | NP level |
NCT00525421 | A Clinical Study of Curcuminoids in the Treatment of Oral Lichen Planus | oral lichen planus | Curcumin (NPC109083) | NP level |
NCT04896164 | Randomized Trial of Curcumin to Reduce Mucositis in Autologous Transplant Setting | oral mucositis | Curcumin (NPC109083) | NP level |
NCT01893281 | The Effect of Testosterone Topical Solution (LY900011) in Hypogonadal Men With Suboptimal Response to a Topical Testosterone Gel | hypogonadism | Testosterone (NPC161423) | NP level |
NCT02256865 | Hormonal Mechanisms of Sleep Restriction | insulin resistance | Testosterone (NPC161423) | NP level |
NCT00164749 | A Pilot Study of Curcumin and Ginkgo for Treating Alzheimer's Disease | Alzheimer disease | Curcumin (NPC109083) | NP level |
NCT00522431 | A Study of Fortigel Testosterone Gel 2% in Males With Low Testosterone | hypogonadism | Testosterone (NPC161423) | NP level |
NCT00247026 | The Efficacy of Coenzyme Q10 And Curcumin in Patients With Myelodysplastic Syndromes | myelodysplastic syndrome | Curcumin (NPC109083) | NP level |
NCT02317640 | TRT in Combination With Electrical Stimulation and Standing: Effect on Muscle and Bone in Spinal Cord Injured Males | Spinal cord injury | Testosterone (NPC161423) | NP level |
NCT00647868 | NASOBOL in Hypogonadal Men in Comparison to Testosterone Levels in Normal Healthy Male Volunteers | hypogonadism | Testosterone (NPC161423) | NP level |
NCT01386606 | The Effect on Androxal Versus Androgel on Morning Testosterone in Men With Secondary Hypogonadism (Low Testosterone) | hypogonadotropic hypogonadism | Testosterone (NPC161423) | NP level |
NCT00965341 | Testosterone Replacement for Fatigue in Male Hypogonadic Advanced Cancer Patients | cancer | Testosterone (NPC161423) | NP level |
NCT02724618 | Nanocurcumin for Prostate Cancer Patients Undergoing Radiotherapy (RT) | prostate cancer | Curcumin (NPC109083) | NP level |
NCT03203681 | Natesto Effects on Testosterone, Luteinizing Hormone, Follicle Stimulating Hormone and Semen Parameters | hypogonadism | Testosterone (NPC161423) | NP level |
NCT01228071 | Time to Eugonadal Range, Time to Steady State and Drying Time | hypogonadism | Testosterone (NPC161423) | NP level |
NCT00467259 | Endometrial Safety Study of Transdermal Testosterone (300 Mcg/Day) in Naturally Postmenopausal Women | sexual dysfunction | Testosterone (NPC161423) | NP level |
NCT01092858 | NEBIDO in Symptomatic Late Onset Hypogonadism (SLOH) | hypogonadism | Testosterone (NPC161423) | NP level |
NCT03339635 | Short-term Testosterone Replacement in Testicular Cancer Survivors | testicular carcinoma | Testosterone (NPC161423) | NP level |
NCT02064673 | Adjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical Prostatectomy | prostate cancer | Curcumin (NPC109083) | NP level |
NCT02433730 | Testosterone Therapy in Hypogonadal Men Treated With Opioids | hypogonadism | Testosterone (NPC161423) | NP level |
NCT00140153 | Testosterone in Female Hypoactive Sexual Desire Disorder | sexual dysfunction | Testosterone (NPC161423) | NP level |
NCT00663793 | ORAL T-6: Oral Androgens in Man-6 | hypogonadism | Testosterone (NPC161423) | NP level |
NCT02111434 | Visceral Adiposity Index and Triglyceride/High-density Lipoprotein Cholesterol Ratio in the Congenital Hypogonadotropic Hypogonadism and Effect of Testosteron Treatment | hypogonadism | Testosterone (NPC161423) | NP level |
NCT03845322 | Curcumin/Turmeric as a Treatment for Patients With Subdural Hematomas Recurrence | intracranial subdural hematoma | Curcumin (NPC109083) | NP level |
NCT01743235 | Lybridos in Pre- and Postmenopausal Women With Hypoactive Sexual Desire Disorder Due to Maladaptive Activation of Sexual Inhibitory Systems | sexual dysfunction | Testosterone (NPC161423) | NP level |
NCT00027495 | Curcumin for the Prevention of Colon Cancer | colorectal carcinoma | Curcumin (NPC109083) | NP level |
NCT03192059 | Study of Pembrolizumab, Radiation and Immune Modulatory Cocktail in Cervical/Uterine Cancer | cervical cancer;endometrial cancer | Curcumin (NPC109083) | NP level |
NCT01235754 | Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) | sexual dysfunction | Testosterone (NPC161423) | NP level |
NCT03091348 | Subcutaneous vs. Intramuscular Testosterone | hypogonadism | Testosterone (NPC161423) | NP level |
NCT00331123 | Study of Transdermal Testosterone Patches in Surgically Menopausal Women With Low Libido | sexual dysfunction | Testosterone (NPC161423) | NP level |
NCT01928043 | Adjunctive Curcumin for Symptomatic Adolescents With Bipolar Disorder: Brain and Body Considerations | bipolar disorder | Curcumin (NPC109083) | NP level |
NCT00331214 | Study of Transdermal Testosterone Patches in Surgically Menopausal Women With Low Libido | sexual dysfunction | Testosterone (NPC161423) | NP level |
How do we define the Plant-Targeted Human Disease Association?
Associated human diseases of an individual plant are summurized based on FOUR types of association evidence, these include:
❶ Association by Therapeutic Target: Bioactive protein targets of the plant were defined in "Molecular Targets" section, target-disease associations collected from TTD database were subsequently used to build the associations between the plant and its targeted human diseases.
❷ Association by Disease Gene Reversion: Plant and a specific disease will be associated when >= 1 plant target gene overlaped with disease's DEGs.
❸ Association by Clinical Trials of Plant: Plant and a specific disease will be associated when >= 1 clinical trial (the plant is the intervetion) can be matched in ClinicalTrials.gov database.
❹ Association by Clinical Trials of Plant Ingredients: Plant and a specific disease will be associated when >= 1 clinical trial (the plant ingredient is the intervetion) can be matched in ClinicalTrials.gov database.
Associated Disease of the Plant |
Association Type & Detailed Evidence |
---|---|
Carcinosarcoma of uterusDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C76.43 |
CYP19A1,SERPINA6,TSHR,GSTP1,GLO1,CISD1,PTGES,NPSR1,CA2
|
Solid tumour/cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00-2F9Z |
MAPK1,MAP2K1,RELA,ALOX5,F3,APP,CA2,GSTP1
|
Breast cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C60-2C6Y |
CYP19A1,CA2,AR
NCT03072992,NCT03980509,NCT00852332,NCT01740323,NCT01042938 |
Gonadotropin deficiencyDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A61.2 |
NCT02419105,NCT01665599,NCT00705796,NCT04523480,NCT01370369,NCT02111473,NCT00244023,NCT02149264,NCT01127659,NCT01386606,NCT02937740,NCT00857168,NCT03091348,NCT00663793,NCT01252745,NCT04976595,NCT00433199,NCT01419236,NCT02110368,NCT02722278,NCT00398580,NCT00957528,NCT01816295,NCT01993225,NCT03118479,NCT01092858,NCT00372008,NCT00857961,NCT00647868,NCT00345969,NCT02081300,NCT01703741,NCT04274894,NCT03203681,NCT02147964,NCT00857454,NCT00522431,NCT00400335,NCT01386567,NCT04558567,NCT01228071,NCT02433730,NCT02712944,NCT04492553,NCT01887418,NCT00161421,NCT00702650,NCT01270841,NCT02847806,NCT01993212,NCT00254553,NCT01446042,NCT03281187,NCT03345797,NCT00962637,NCT01323140,NCT04439799,NCT01699178,NCT02111434,NCT01403116,NCT00998933,NCT00304213,NCT01786473,NCT00431197,NCT01893281,NCT01133548,NCT00706719,NCT00161486,NCT00204269,NCT03198728
|
Alzheimer diseaseDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A20 |
APP,PTGES,MAOA,CACNA1C,SNCA
NCT00164749,NCT00099710 |
Serous cystadenoma,borderline malignancy of ovaryDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C73.4 |
TSHR,GSTP1,GLO1,CISD1,ALOX5,PTGES,CA2
|
Colorectal cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B91 |
GSTP1
NCT01333917,NCT02439385,NCT00027495,NCT01859858,NCT00973869 |
PheochromocytomaDisease Category: X.Extension CodesDisease ICD-11 Code: XH3854 |
PTGES,CACNA1C,APP,SNCA,CA2,FOS
|
Malignant neoplasms of biliary tract, distal bile ductDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C15 |
GSTP1,F3,ALOX5,PTGES,CACNA1C,LMNA
|
Mesothelioma of pleuraDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C26.0 |
GSTP1,ALOX5,PTGES,SNCA,SMN1,LMNA
|
Malignant neoplasms of adrenal glandDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D11 |
AR,HSD17B3,GLO1,PTGES,SNCA,CYP19A1
|
Multiple sclerosisDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A40 |
RELA
NCT00405353,NCT03000127,NCT02317263,NCT01514370 |
Other specified malignant neoplasms of kidney, except renal pelvisDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C90.Y |
ALOX5,CYP19A1,HSD17B3,ALOX5,TSHR
|
Superficial ovarian endometriosisDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA10.B4 |
GSTP1,PTGES,SNCA,CA2,LMNA
|
Glioblastoma of brainDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00.00 |
CYP19A1,AR,TSHR,CA2,LMNA
|
Heart failureDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD10-BD1Z |
AR,CA2
NCT01469988,NCT00957034 |
Ageing associated decline in intrinsic capacityDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG2A |
NCT02990533,NCT00309855,NCT02679274,NCT02203656
|
Unspecified malignant neoplasms of unspecified sitesDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D4Z |
NCT01201694,NCT01608139,NCT02138955,NCT00965341
|
HepatoblastomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C12.01 |
CYP19A1,GSTP1,PTGES,CACNA1C
|
Squamous cell carcinoma of bronchus or lungDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25.2 |
TSHR,HSD17B3,PTGES,NPSR1
|
Melanoma of skinDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C30 |
GSTP1,APP,SHBG,ALDH1A1
|
Chikungunya virus diseaseDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D40 |
CYP19A1,PTGES,F3,LMNA
|
AsthmaDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA23 |
SERPINA6,ALOX5
NCT04353310 |
Rheumatoid arthritisDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA20 |
RELA,ALOX5,CA2
|
Lung cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25 |
ALOX5,MAP2K1,GSTP1
|
Chronic kidney diseaseDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GB61 |
AR
NCT02369549,NCT02418065 |
Pancreatic cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10 |
MAPK1,GSTP1,F3
|
Injury of spinal cord, level unspecifiedDisease Category: 22.Injury, poisoning or certain other consequences of external causesDisease ICD-11 Code: ND51.2 |
NCT03345576,NCT01652040,NCT02317640
|
Ulcerative colitisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD71 |
NCT01320436,NCT00889161,NCT02277223
|
Metabolic disorderDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C50-5D2Z |
NCT00382057,NCT00479609,NCT00438321
|
Other specified malignant neoplasms of colonDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B90.Y |
NCT00641147,NCT00118989,NCT00248053
|
Oral mucositisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA01 |
NCT04870060,NCT04896164,NCT02300727
|
Crohn diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD70 |
NCT00889161,NCT02255370,NCT04713631
|
Systemic lupus erythematosusDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A40.0 |
F3
NCT05430087,NCT03953261 |
Adenocarcinoma of stomachDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B72.0 |
CYP19A1,SERPINA6,NPSR1
|
Hepatocellular carcinoma of liverDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C12.02 |
CYP19A1,PTGES,CYP19A1
|
Urothelial carcinoma of bladderDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C94.2 |
SERPINA6,HSD17B3,CA2
|
Cytomegaloviral diseaseDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D82 |
HSD17B3,CA2,FOS
|
Adenocarcinoma of bronchus or lungDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25.0 |
TSHR,PTGES,NPSR1
|
InfluenzaDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1E30-1E32 |
ALOX5,GLO1
|
Postoperative inflammationDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1A00-CA43 |
SERPINA6,ALOX5
|
Low bone mass disorderDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FB83 |
CA2,AR
|
RetinopathyDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9B71 |
APP,SERPINA6
|
Muscular atrophyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B61 |
SMN2,SMN1
|
Atopic eczemaDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EA80 |
ALOX5,RELA
|
Fungal infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F29-1F2F |
RELA,ALOX5
|
Pituitary gland disorderDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A60-5A61 |
AR,ALOX5
|
MelanomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C30 |
MAPK1,MAP2K1
|
ParkinsonismDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A00 |
MAOA,SNCA
|
Muscular dystrophyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C70 |
AR,RELA
|
Substance abuseDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6C40 |
ALDH1A1,MAOA
|
Myelodysplastic syndromeDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A37 |
GSTP1
NCT00247026 |
Acute myeloid leukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A60 |
AR,RELA
|
PsoriasisDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EA90 |
ALOX5,RELA
|
Thyroid cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D10 |
TSHR,MAP2K1
|
Male erectile dysfunctionDisease Category: 17.Conditions related to sexual healthDisease ICD-11 Code: HA01.1 |
NCT00244023,NCT00202163
|
Oral submucous fibrosisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA02.2 |
NCT03511261,NCT02645656
|
ObesityDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5B80-5B81 |
NCT01616732,NCT01160328
|
Nicotine use disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6C4A |
NCT04837664,NCT00365209
|
Type1diabetesmellitusDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A10 |
NCT02529982,NCT02529969
|
Cervical cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C77 |
NCT03192059,NCT04294836
|
Symptoms and signs involving cognition, unspecifiedDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MB21.Z |
NCT01383161,NCT01811381
|
Male infertilityDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GB04 |
NCT03378713,NCT03238092
|
Periodontal diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA0C |
NCT04355416,NCT03790605
|
ProteinuriaDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MF96 |
NCT01831193,NCT03019848
|
Macular degenerationDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9B75 |
NCT04590196,NCT05062486
|
Lichen planusDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EA91 |
NCT00525421,NCT00226174
|
Malignant neoplasm of pancreas, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10.Z |
NCT00486460,NCT00192842
|
Malignant neoplasm metastasis in lymph nodes of head, face or neckDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D60.0 |
HSD17B3,NPSR1
|
Malignant neoplasms of oesophagusDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B70 |
PTGES,NPSR1
|
Malignant neoplasms of corpus uteri, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C76.Z |
NPSR1,CA2
|
Malignant neoplasms of thymusDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C27 |
CISD1,PTGES
|
Sexual dysfunctionDisease Category: 17.Conditions related to sexual healthDisease ICD-11 Code: HA00-HA01 |
NCT00384046,NCT00613002,NCT01096329,NCT00075855,NCT00698035,NCT00467259,NCT01432665,NCT01364623,NCT00349791,NCT00657501,NCT00331123,NCT00338312,NCT00140153,NCT02101203,NCT01235754,NCT00331214,NCT00612742,NCT01743235,NCT00131495
|
Prostate cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C82 |
MAOA,AR
NCT00006044,NCT00587431,NCT00577980,NCT02064673,NCT03734653,NCT02724618,NCT02095717,NCT00515112,NCT04403568,NCT03769766 |
Diffuse large B-cell lymphomasDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A81 |
PLAA,TSHR,AR,GSTP1,GLO1,F3,CISD1,PTGES,CACNA1C,SMN1,ALDH1A1,LMNA
|
Germ cell tumour of testisDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C80.2 |
PLAA,SERPINA6,GLO1,MAP3K7,MAPK1,ALOX5,NPSR1,APP,SNCA,SMN1,MAP2K1
|
Adenocarcinoma of pancreasDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10.0 |
GSTP1,CISD1,ALOX5,PTGES,CACNA1C,APP,NPSR1,SNCA,CA2,LMNA
|
General pain disorderDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8E43 |
MAOA
|
Mammary tumourDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C60-2C6Z |
AR
|
Carcinoid syndromeDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5B10 |
ALOX5
|
Respiratory system diseaseDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CB40-CB7Z |
SERPINA6
|
Hypo-thyroidismDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A00 |
TSHR
|
Duodenal ulcerDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA63 |
CA2
|
Diagnostic imagingDisease Category: NADisease ICD-11 Code: N.A. |
APP
|
Skin and skin-structure infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F28-1G0Z |
RELA
|
EndometriosisDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA10 |
CYP19A1
|
Bleeding disorderDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA20-GA21 |
F3
|
Cushing syndromeDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A70 |
CYP19A1
|
Dystrophic epidermolysis bullosaDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EC32 |
APP
|
Pain, unspecifiedDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG3Z |
ALOX5
|
ThrombocytopeniaDisease Category: 03.Diseases of the blood or blood-forming organsDisease ICD-11 Code: 3B64 |
ALOX5
|
Desmoid tumourDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2F7C |
APP
|
Female pelvic painDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA34 |
AR
|
Muscle disorderDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FB32-FB3Z |
AR
|
Acute respiratory distress syndromeDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CB00 |
F3
|
Type 2 diabetes mellitusDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A11 |
RELA
|
Mood disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A60-6E23 |
MAOA
|
Skin tag/polypDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EK71 |
MAOA
|
AlopeciaDisease Category: 14.Diseases of the skinDisease ICD-11 Code: ED70 |
AR
|
Diabetes mellitus, type unspecifiedDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A14 |
RELA
|
InsomniaDisease Category: 07.Sleep-wake disordersDisease ICD-11 Code: 7A00-7A0Z |
CA2
|
Idiopathic interstitial pneumonitisDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CB03 |
ALOX5
|
OesophagitisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA24 |
CYP19A1
|
Indeterminate colitisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD72 |
RELA
|
NeuropathyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C0Z |
CYP19A1
|
Irritable bowel syndromeDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD91 |
RELA
|
Seborrhoeic dermatitisDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EA81 |
CA2
|
Acute/subacute hepatic failureDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB91 |
RELA
|
DepressionDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A70-6A7Z |
MAOA
|
Prostate hyperplasiaDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA90 |
AR
|
Hypo-osmolality/hyponatraemiaDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C72 |
AR
|
GlaucomaDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9C61 |
CA2
|
FilariasisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F66 |
ALOX5
|
Chronic obstructive pulmonary diseaseDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA22 |
AR
|
Acquired hypomelanotic disorderDisease Category: 14.Diseases of the skinDisease ICD-11 Code: ED63 |
MAOA
|
Autonomic nervous system disorderDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8D87 |
SNCA
|
AmyloidosisDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5D00 |
APP
|
Nasopharyngeal cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B6B |
ALOX5
|
Acne vulgarisDisease Category: 14.Diseases of the skinDisease ICD-11 Code: ED80 |
AR
|
Testicular dysfunctionDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A81 |
AR
|
Lupus erythematosusDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A40 |
RELA
|
Choreiform disorderDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A01 |
RELA
|
Bacterial infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1A00-1C4Z |
CA2
|
Alcoholic liver diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB94 |
AR
|
Arteries/arterioles disorderDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD52 |
MAPK1
|
Essential hypertensionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA00 |
CA2
|
Cardiovascular diseaseDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA00-BE2Z |
AR
|
ThrombosisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB61-GB90 |
AR
|
Non-small cell lung cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25 |
NCT01048983
|
Insulin-resistance syndromesDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A44 |
NCT02256865
|
Cervical intraepithelial neoplasiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2E66 |
NCT02554344
|
Testicular cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C80 |
NCT03339635
|
Sex development malformative disorderDisease Category: 20.Developmental anomaliesDisease ICD-11 Code: LD2A |
NCT04831099
|
Adenocarcinoma, endocervical typeDisease Category: X.Extension CodesDisease ICD-11 Code: XH0GS9 |
NCT04266275
|
DyspareuniaDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA12 |
NCT01697345
|
Malignant neoplasms of rectum, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B92.Z |
NCT00745134
|
Penile fibromatosisDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GB06.2 |
NCT01578473
|
Hereditary breast and ovarian cancer syndromeDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C65 |
NCT00080756
|
coronary artery diseaseDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA8Y-BA8Z |
NCT00413244
|
Precursor cell lymphoblastic leukaemia, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH5J37 |
NCT05045443
|
Diseases of the nervous systemDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 08 |
NCT02848417
|
Endometrial cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C76 |
NCT03192059
|
Other specified mitochondrial myopathiesDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C73.Y |
NCT00528151
|
Fracture of neck of femur, unspecifiedDisease Category: 22.Injury, poisoning or certain other consequences of external causesDisease ICD-11 Code: NC72.2Z |
NCT00345969
|
Other specified disorders of musclesDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FB32.Y |
NCT00183040
|
NeoplasmsDisease Category: 02.NeoplasmsDisease ICD-11 Code: 02 |
NCT02944578
|
Congenital human immunodeficiency virus infectionDisease Category: 19.Certain conditions originating in the perinatal periodDisease ICD-11 Code: KA62.6 |
NCT00006158
|
MenopauseDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA30.0 |
NCT02445716
|
CoughDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MD12 |
NCT01119534
|
Neoplasms of unknown behaviour of colonDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2F90.0 |
NCT00295035
|
Malignant neoplasms of prostate, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C82.Z |
NCT00586898
|
Malignant neoplasm metastasis in male genital organsDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2E06 |
NCT05011383
|
Traumatic subdural haemorrhageDisease Category: 22.Injury, poisoning or certain other consequences of external causesDisease ICD-11 Code: NA07.6 |
NCT03845322
|
NADisease Category: NADisease ICD-11 Code: NA |
NCT01797718
|
Bipolar disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A60 |
NCT01928043
|
Primary sclerosing cholangitisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB96.2 |
NCT02978339
|
Cutaneous T-cell lymphoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH1951 |
NCT00969085
|
Low grade squamous intraepithelial lesion of cervix uteriDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA15.7 |
NCT01035580
|
Multiple myelomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A83 |
NCT01269203
|
Dermatoses due to ionizing radiation, unspecifiedDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EJ7Z |
NCT01246973
|
Chronic lymphocytic leukaemia or small lymphocytic lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A82.0 |
NCT02100423
|
Chronic atrophic gastritis of unknown aetiologyDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA42.73 |
NCT02782949
|
Malignant neoplasms of colonDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B90 |
NCT01294072
|
Disorders of muscles, unspecifiedDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FB3Z |
NCT02873559
|
Polycystic ovary syndromeDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A80.1 |
NCT00757185
|
Asymptomatic stenosis of intracranial or extracranial arteryDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD55 |
NCT04265053
|
Noninfectious erosive or ulcerative disorders of oral mucosaDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA01.1 |
NCT05147376
|
Anorexia nervosaDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6B80 |
NCT00089843
|
Coeliac diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA95 |
TSHR
|
Myelodysplastic syndromes, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A3Z |
TSHR
|
Osteoarthritis, unspecifiedDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA0Z |
PTGES
|
Dengue fever, unspecifiedDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D2Z |
MAOA
|
LeishmaniasisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F54 |
TSHR
|
West Nile virus infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D46 |
CYP19A1
|
Tetralogy of FallotDisease Category: 20.Developmental anomaliesDisease ICD-11 Code: LA88.2 |
F3
|
Other specified malignant neoplasms ofcolonDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B90.Y |
NPSR1
|
Adenocarcinoma of prostateDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C82.0 |
SERPINA6
|
Malignant neoplasms of thyroid gland, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D10.Z |
ALOX5
|
Parkinson diseaseDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A00.0 |
ALDH1A1
|
Invasive carcinoma of breastDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C61 |
SERPINA6
|
Malaria, unspecifiedDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F4Z |
PTGES
|
Human immunodeficiency virus disease without mention of tuberculosis or malariaDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1C62 |
FOS
|
Renal cell carcinoma, chromophobe typeDisease Category: X.Extension CodesDisease ICD-11 Code: XH6153 |
CA2
|